Cell-To-Cell Communication in Health and Disease
Principal Investigator
Michael Risner, PhD
Oakland University William Beaumont School of Medicine
Rochester, MI, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$196,512
Active Dates
July 01, 2022 - June 30, 2025
Grant ID
G2022011S
Co-Principal Investigator(s)
David Calkins, PhD, Vanderbilt University Medical Center
Goals
The goal of this project is to understand mechanisms of intercellular communication in the context of cell-replacement therapy.
Grantee institution at the time of this grant: Vanderbilt University Medical Center
Summary
Using high-resolution microscopy, we will investigate mitochondrial trafficking through tunneling nanotubes, which are thin protrusions that extend from the plasma membrane, between human embryonic stem cell derived retinal ganglion cells and astrocytes under physiologic (Aim 1) and pathologic conditions (Aim 2).
Unique and Innovative
We are the first to investigate regulatory mechanisms of intercellular mitochondrial transfer in human-derived cells in the context of developing treatments for glaucoma.
Foreseeable Benefits
These studies will explore a potential compensatory pathway for the upregulation of intercellular mitochondrial transfer during stress. We will employ gene-based interventions to reduce and increase intercellular trafficking of mitochondria and determine the influence of each strategy on cell health.
Related Grants
National Glaucoma Research
Improving Glaucoma Care with Agentic AI
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Mark Christopher, PhD
Current Organization
University of California, San Diego
Improving Glaucoma Care with Agentic AI
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Mark Christopher, PhD
Current Organization
University of California, San Diego
National Glaucoma Research
Measuring the Effects of Visual Stimuli on Retinal Blood Vessels and Flow
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Stuart Gardiner, PhD
Current Organization
Good Samaritan Foundation, Legacy Health System
Measuring the Effects of Visual Stimuli on Retinal Blood Vessels and Flow
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Stuart Gardiner, PhD
Current Organization
Good Samaritan Foundation, Legacy Health System
National Glaucoma Research
Activating the Eye’s Own Nitric Oxide to Fight Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Myoungsup Sim, PhD
Current Organization
Duke University School of Medicine
Activating the Eye’s Own Nitric Oxide to Fight Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Myoungsup Sim, PhD
Current Organization
Duke University School of Medicine